Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Bitcoin Trust (IBIT) vs Merck & Co., Inc. (MRK) Price & Performance

iShares Bitcoin TrustTrade
Merck & Co., Inc.Trade

Price performance (Past 24H)

Key statistics

iShares Bitcoin Trust vs Merck & Co., Inc. — how do they compare? iShares Bitcoin Trust trades at $36.27, while Merck & Co., Inc. trades at $130.01 (market cap $321.77B). The key difference: Merck & Co., Inc. pays a 2.61% dividend while iShares Bitcoin Trust pays none, and Merck & Co., Inc. is trading nearer its 52-week high, iShares Bitcoin Trust nearer its low. Which is the better fit depends on your goals.

IBITMRK
Sector
Crypto-linkedHealth
52-Week High
$71.29$131.84
52-Week Low
$33.29$77.60
Market Cap
$321.77B
Enterprise Value
$368.53B
Dividend Yield
2.61%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Bitcoin Trust

No Aura AI signal available yet.

Merck & Co., Inc.

Merck (MRK) trades at $130.90, up 1.81% on the day, with a bullish technical outlook and strong institutional support. Recent earnings beats in Q4 2025 and Q1-Q2 2026, alongside a 28.07% net income margin in 2025, highlight operational strength. The acquisition of Terns Pharmaceuticals aims to bolster its oncology pipeline, though a high P/E of 104.74 signals premium valuation. Cash flow remains positive at $1.37B in 2025, but investing outflows have increased.

The stock offers growth potential from pipeline expansion and analyst consensus targeting $140.36, but risks include elevated debt-to-asset ratios (36.06% in 2025) and competitive pressures. Investors should weigh robust profitability against valuation concerns and macroeconomic headwinds affecting the pharma sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About iShares Bitcoin Trust

IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.

Read more on IBIT

About Merck & Co., Inc.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.

Read more on MRK